EXACT Therapeutics minutes from Annual General Meeting June 13, 2025

13 Jun 2025 12:05 CEST

OSLO, 13 June 2025: EXACT Therapeutics AS (“EXACT-Tx”, “the Company” Euronext
Growth: EXTX) held its Annual General Meeting on June 13, 2025 at 10:30 CEST.

All proposed resolutions were approved.

Please find enclosed the minutes of the meeting including appendices. The
minutes will also be available on the company website: www.exact-tx.com



For more information, please contact:

Per Walday, CEO
EXACT Therapeutics
Email per.walday@exact-tx.com

John M. Edminson CFO
EXACT Therapeutics
Email: john.edminson@exact-tx.com

About EXACT-Tx:
EXACT-Tx is a clinical-stage precision medicine company utilizing the power of
ultrasound and microbubbles to enable targeted drug delivery in oncology.
Acoustic Cluster Therapy (ACT®) follows a unique approach and may be applied to
a wide range of therapeutic agents across a multitude of indications including
within oncology (chemotherapy, immunotherapy) and brain diseases.
www.exact-tx.com

More information:
Access the news on Oslo Bors NewsWeb site

649109_20250613_EXACT_Therapeutics_AS_AGM.pdf